403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Movida, MBRF And Natura Q3 2025 Results
(MENAFN- The Rio Times) Brazil's earnings day offered a simple trio for global readers: a car-rental operator (Movida) showing that execution still trumps headwinds; a protein champion (MBRF, the Marfrig-BRF combination) proving that scale is real but must be paid down; and a beauty retailer (Natura) wrestling with integration, margins, and cash.
The real story behind the numbers is how companies are protecting profitability in a slower economy: smarter pricing and cost control, portfolio breadth to ride uneven cycles, and liquidity discipline to keep optionality alive.
Movida - Vehicle rentals with a disciplined operating engine
What it does: car rentals (retail and corporate), fleet management, and used-car sales.
Story and numbers: Movida 's net income was R$ 70 million ($13 million), down year on year, but operations beat expectations as consolidated EBITDA hit R$ 1.48 billion ($274 million).
The rent-a-car unit led the outperformance, with Portugal a clear bright spot, while Brazil contributed modest gains. A heavier-than-hoped financial result offset part of the operating strength, partly cushioned by a tax effect of R$ 11 million ($2 million). Leverage eased to 2.7x.
Management's levers-AI pricing, in-house“PitStop” maintenance, and digital processes-kept unit costs in check, and used-car margins held up. Guidance for 4Q25 net income of R$ 75–90 million ($14–17 million) points to momentum.
Behind the story: The rental model is proving it can protect margin even as rates bite. The watch item is financing cost; if it normalizes, today's operating gains can translate into stronger free cash flow.
MBRF - Global protein scale, but deleveraging will set the valuation
What it does: one of the world's largest protein platforms (beef, poultry, processed foods) after the Marfrig-BRF combination.
Story and numbers: Net revenue reached R$ 42 billion ($7.8 billion). Adjusted EBITDA was R$ 3.5 billion ($648 million).
Adjusted net income printed R$ 680 million ($126 million). Volumes hit 2.10 million tonnes, with South America beef and BRF's processed portfolio doing the lifting.
Net debt rose to R$ 48.3 billion ($8.9 billion) after dividends of R$ 3.8 billion ($704 million) and buybacks of R$ 731 million ($135 million); free cash flow was R$ 383 million ($71 million). The board expanded share repurchases by up to 64.6 million shares through March 2027.
Behind the story: The platform is working-diversified proteins, geographies, and brands-but the market will reward consistent deleveraging and proof that poultry and U.S. beef cycles are normalizing.
The halal push (Sadia Halal) adds a medium-term growth and monetization option; debt trajectory remains the swing factor.
Natura - Beauty retail under pressure; execution and cash are the near-term tests
What it does: direct-to-consumer beauty across Latin America and select international markets.
Story and numbers: Adjusted EBITDA fell to R$ 577 million ($107 million); the company posted a net loss of R$ 119 million ($22 million). Free cash flow was negative R$ 47 million ($9 million).
Net debt was about R$ 4.0 billion ($741 million), taking leverage close to 3x. Management reiterated its 2025 EBITDA -margin expansion target, but Wave 2 integration (notably Mexico and Argentina) and a softer Brazil consumer hurt sell-out and margins.
Transformation costs for 2025 may reach up to R$ 483 million ($89 million), implying as much as R$ 160 million ($30 million) in 4Q if the ceiling is met. The planned sale of Avon International by 1Q26 lowers structural risk but introduces timing risk.
Behind the story: This is a rebuild. Until Brazil sell-out stabilizes, Wave 2 milestones land, and cash generation turns positive, upside is capped-even with valuable brands.
The takeaway
Execution can still beat macro (Movida), scale must be matched by balance-sheet progress (MBRF), and turnarounds demand patience and cash (Natura). For global investors, Brazil's corporate winners are those converting operational ingenuity into durable free cash flow.
The real story behind the numbers is how companies are protecting profitability in a slower economy: smarter pricing and cost control, portfolio breadth to ride uneven cycles, and liquidity discipline to keep optionality alive.
Movida - Vehicle rentals with a disciplined operating engine
What it does: car rentals (retail and corporate), fleet management, and used-car sales.
Story and numbers: Movida 's net income was R$ 70 million ($13 million), down year on year, but operations beat expectations as consolidated EBITDA hit R$ 1.48 billion ($274 million).
The rent-a-car unit led the outperformance, with Portugal a clear bright spot, while Brazil contributed modest gains. A heavier-than-hoped financial result offset part of the operating strength, partly cushioned by a tax effect of R$ 11 million ($2 million). Leverage eased to 2.7x.
Management's levers-AI pricing, in-house“PitStop” maintenance, and digital processes-kept unit costs in check, and used-car margins held up. Guidance for 4Q25 net income of R$ 75–90 million ($14–17 million) points to momentum.
Behind the story: The rental model is proving it can protect margin even as rates bite. The watch item is financing cost; if it normalizes, today's operating gains can translate into stronger free cash flow.
MBRF - Global protein scale, but deleveraging will set the valuation
What it does: one of the world's largest protein platforms (beef, poultry, processed foods) after the Marfrig-BRF combination.
Story and numbers: Net revenue reached R$ 42 billion ($7.8 billion). Adjusted EBITDA was R$ 3.5 billion ($648 million).
Adjusted net income printed R$ 680 million ($126 million). Volumes hit 2.10 million tonnes, with South America beef and BRF's processed portfolio doing the lifting.
Net debt rose to R$ 48.3 billion ($8.9 billion) after dividends of R$ 3.8 billion ($704 million) and buybacks of R$ 731 million ($135 million); free cash flow was R$ 383 million ($71 million). The board expanded share repurchases by up to 64.6 million shares through March 2027.
Behind the story: The platform is working-diversified proteins, geographies, and brands-but the market will reward consistent deleveraging and proof that poultry and U.S. beef cycles are normalizing.
The halal push (Sadia Halal) adds a medium-term growth and monetization option; debt trajectory remains the swing factor.
Natura - Beauty retail under pressure; execution and cash are the near-term tests
What it does: direct-to-consumer beauty across Latin America and select international markets.
Story and numbers: Adjusted EBITDA fell to R$ 577 million ($107 million); the company posted a net loss of R$ 119 million ($22 million). Free cash flow was negative R$ 47 million ($9 million).
Net debt was about R$ 4.0 billion ($741 million), taking leverage close to 3x. Management reiterated its 2025 EBITDA -margin expansion target, but Wave 2 integration (notably Mexico and Argentina) and a softer Brazil consumer hurt sell-out and margins.
Transformation costs for 2025 may reach up to R$ 483 million ($89 million), implying as much as R$ 160 million ($30 million) in 4Q if the ceiling is met. The planned sale of Avon International by 1Q26 lowers structural risk but introduces timing risk.
Behind the story: This is a rebuild. Until Brazil sell-out stabilizes, Wave 2 milestones land, and cash generation turns positive, upside is capped-even with valuable brands.
The takeaway
Execution can still beat macro (Movida), scale must be matched by balance-sheet progress (MBRF), and turnarounds demand patience and cash (Natura). For global investors, Brazil's corporate winners are those converting operational ingenuity into durable free cash flow.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment